The Latest Pharmacology of Infectious Diseases & Immunizations: Now with Critical Corona Virus Updates – Jason Cota

The world of pharmacology, infectious diseases, and immunizations is constantly evolving.As new guidelines are released, modern evidence published, and critical information updated… are you confident you can keep up with it?You can with our new-and-improved online course — The Latest Pharmacology of Infectious Diseases & Immunizations: Now with Critical Coronavirus Updates.This self-paced video training gives you:Practice at the forefront of current infectious disease evidenceInsights into WHY an agent should be prescribed in a clinical scenarioThe confidence to know WHEN it’s safe to use a cephalosporin in a patient with a history of penicillin reactionTips to combat bacterial resistance — with an emphasis on new antimicrobials and advances in evidence-based treatment guidelinesSkills to expertly interpret culture and sensitivity resultsUp to 13.75 total contact hours – INCLUDING 8.6 pharmacology CE hours…And so much more!Gain the most up-to-date knowledge you will want to share with your colleagues!Get started today and become the pharmacology expert on your unit by your very next shift!It’s critical for your patients that you stay up-to-date on proper prescribing, patient education, and monitoring procedures for a variety of drug regimens used to treat common acute and chronic infectious diseases.Get The Latest Pharmacology of Infectious Diseases & Immunizations: Now with Critical Corona Virus Updates – Jason Cota , Only Price $67Here’s what you’ll cover in this state-of-the-art online training course:Pharmacology of Infectious Diseases & Immunizations for Advanced Practice Clinicians — with Jason Cota, PharmaD, MSAntimicrobialsDrug classesPharmacokinetic PropertiesConcentration-dependent killingTime-dependent killingPost-antibiotic effectCommon interactions with other drugsAntibacterial Allergies — Sulfa and PenicillinDefine true allergySulfonamide antibiotics vs non-antibioticsPenicillin — Cephalosporin cross-sensitivityBacteriaDifferentiationNormal floraCommon pathogensAntibacterial Resistance — Contributing FactorsTrendsMechanisms of resistanceContributing factorsMethicillin-Resistant Staphylococcus Aureus — Community versus Hospital AcquiredDifferentiating between CA- and HA-MRSACurrent clinical practice guidelinesPharmacologic managementEnterobacteriaceae ResistanceExtended Spectrum Beta-Lactamase (ESBL)What are ESBLsPharmacologic managementCarbapenem-Resistant Enterobacteriaceae (CRE)What are CREsPharmacologic managementUrinary Tract InfectionsBacterial Etiology, Signs and Symptoms and DiagnosisCystitis and pyelonephritisComplicated and uncomplicatedUTIs in pregnancyTreatment (IDSA Guideline Treatment Algorithm)AcuteRecurrent and relapseClostridium Difficile InfectionRisk factorsPharmacology managementFecal TransplantationProbiotics literature reviewCommunity-Acquired PneumoniaBacterial etiologyDiagnosisTypical vs. atypicalTreatment (IDSA/ATS Guidelines) and monitoringOutpatient vs. inpatientEmpiric treatmentHealthcare-Associated PneumoniaBacterial etiologyTreatment (IDSA/ATS Guidelines)Upper Respiratory Tract InfectionsSinusitis and pharyngitisEtiology (Viral vs. Bacterial)TreatmentSkin and Soft Tissue InfectionsCellulitisBacterial etiologyStrep. vs. Staph. vs. MRSASigns & symptomsTreatment (IDSA Guidelines)InfluenzaClinical featuresDiagnosisPharmacology managementImmunizations (Adult)Types of VaccinesGeneral recommendationsContraindications & precautionsInfection Control Challenges: Real Risks for Patients and Staff — with William “Barry” Inman, BA-BS, CICA Summary of Current Recommendations From the CDC, SHEA, IDSA, APIC and the Joint CommissionGet The Latest Pharmacology of Infectious Diseases & Immunizations: Now with Critical Corona Virus Updates – Jason Cota , Only Price $67Health-Care Associated Infections: Strategies to Control-Reduce-EliminateCatheter-Associated Urinary Tract InfectionsSurgical Site InfectionsVentilator-Associated PneumoniasNon-ventilator Associated Infections (overlooked HAI)Central-Line Associated Bloodstream InfectionsThe Latest Multi-Drug Resistant Microorganism GuidelinesCarbapenem-resistant enterobacteriaceaeClostridium difficileMethicillin-resistant staphylococcus aureusVancomycin resistant enterococcusAcinetobacter baumanniiInfluenzaAvian vs. swine vs. seasonal influenzaH1N1 pandemic resultsWhen to treat? When not to treat?Treatment with anti-virals and antibioticsNew vaccines for fluVaccination Recommendations for Healthcare PersonnelZoster/shinglesPneumoccocalMMR, Tdap, etc.Emerging Infectious Diseases (Zoonotic)Ebola: What we learnedMosquito-borne (“Zika”, Dengue, Chickungunya, West Nile)Tick-borne (Lyme and Babesia)CryptosporidiosisBloodborne PathogensHepatitis BVaccination protocol for healthcare personnelStaff follow-up after significant exposuresTreatments for persons chronically infectedOutbreaks in healthcareHepatitis CTreatment “cures” in 12-24 weeksOutbreaks in healthcare-dialysis settingsHIV/AIDSNew one pill daily treatmentHealthcare exposure and appropriate prophylaxisTuberculosisToday’s best approaches to treatmentSkin testing vs. blood test for exposureFollow-up guidelines for healthcare workers conversion testingGet The Latest Pharmacology of Infectious Diseases & Immunizations: Now with Critical Corona Virus Updates – Jason Cota , Only Price $67Tag: The Latest Pharmacology of Infectious Diseases & Immunizations: Now with Critical Corona Virus Updates – Jason Cota  Review. The Latest Pharmacology of Infectious Diseases & Immunizations: Now with Critical Corona Virus Updates – Jason Cota  download. The Latest Pharmacology of Infectious Diseases & Immunizations: Now with Critical Corona Virus Updates – Jason Cota  discount.